CAM
TGTX icon

Congress Asset Management’s TG Therapeutics TGTX Stock Holding History

Congress Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$145M Buy
2,606,516
+6,393
+0.2% +$346K 0.94% 23
2026
Q2 		$143M Buy
2,600,123
+432,042
+20% +$17.7M 0.88% 31
2026
Q1 		$72M Buy
2,168,081
+245,671
+13% +$7.32M 0.52% 74
2025
Q4 		$57.3M Buy
+1,922,410
New +$62.8M 0.4% 94

Other funds holding TGTX

AWM
Avaii Wealth Management Appleton, Wisconsin $348M AUM 25.11% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Congress Asset Management's TGTX Position: Q3 2026 in Review

Congress Asset Management increased its TG Therapeutics (TGTX) stake by 0.25% in Q3 2026, buying an estimated $346K and bringing the position to 2,606,516 shares worth $145M. The position accounts for 0.94% of the portfolio, ranked #23.

Congress Asset Management first reported a position in TGTX in Q4 2025 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Congress Asset Management held 2,606,516 shares of TG Therapeutics worth $145M as of Q3 2026.
  • Congress Asset Management bought 6,393 TG Therapeutics shares in Q3 2026, an estimated $346K.
  • TG Therapeutics made up 0.94% of Congress Asset Management's portfolio in Q3 2026, its #23 holding.
  • Congress Asset Management first reported a position in TG Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.